Lista de obras - Francesca Cicchetti - Dominio Público Uruguay

A light-inducible protein clustering system for in vivo analysis of α-synuclein aggregation in Parkinson disease

artículo científico publicado en 2022

An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity ⬇️

artículo científico publicado el 30 de agosto de 2012

Anatomy and physiopathology of the basal ganglia

artículo científico publicado el 1 de enero de 1997

Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology

artículo científico publicado en 2015

Correction: Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology

artículo científico publicado en 2020

Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.

artículo científico publicado en 2015

Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primates

scientific article published on 11 May 2020

GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte-neuron interactions

artículo científico publicado en 2016

Human-to-mouse prion-like propagation of mutant huntingtin protein

artículo científico publicado en 2016

Inflammation and neurodegeneration: the story ‘retolled’ ⬇️

artículo científico publicado el 31 de agosto de 2012

Is Huntington's disease a tauopathy?

artículo científico publicado en 2016

Mutant huntingtin is present in neuronal grafts in Huntington disease patients

artículo científico publicado en 2014

MyD88 deficiency results in both cognitive and motor impairments in mice ⬇️

artículo científico publicado el 28 de febrero de 2012

Parkinsonian Motor Deficits Are Reflected by Proportional A9/A10 Dopamine Neuron Degeneration in the Rat ⬇️

artículo científico publicado el 1 de diciembre de 2001

Partial neurorescue effects of DHA following a 6-OHDA lesion of the mouse dopaminergic system.

artículo científico publicado en 2015

Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases ⬇️

artículo científico publicado el 24 de noviembre de 2010

Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease

artículo científico publicado en 2017

Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology

artículo científico publicado en 2020

Single-cell suspension methodology favors survival and vascularization of fetal striatal grafts in the YAC128 mouse model of Huntington's disease.

artículo científico publicado en 2013

Sox6 expression distinguishes dorsally and ventrally biased dopamine neurons in the substantia nigra with distinctive properties and embryonic origins

artículo científico publicado en 2021

Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viability.

artículo científico publicado en 2013

Striatal neurones displaying substance P (NK 1) receptor immunoreactivity in human and non-human primates ⬇️

artículo científico publicado el 27 de marzo de 1995

Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease.

artículo científico publicado en 2014

The different effects of LPS and poly I:C prenatal immune challenges on the behavior, development and inflammatory responses in pregnant mice and their offspring

artículo científico publicado en 2013

The fate of cell grafts for the treatment of Huntington's disease: the post-mortem evidence.

artículo científico

The morphological and molecular changes of brain cells exposed to direct current electric field stimulation.

artículo científico publicado en 2014

The role of immunity in Huntington's disease ⬇️

artículo científico publicado el 26 de abril de 2011

The role of tau in the pathological process and clinical expression of Huntington's disease

artículo científico publicado en 2015

Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease ⬇️

artículo científico publicado el 29 de noviembre de 2010

Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates

scientific article published on 18 May 2020

Lista de obras de Francesca Cicchetti

A light-inducible protein clustering system for in vivo analysis of α-synuclein aggregation in Parkinson disease

An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity ⬇️

Anatomy and physiopathology of the basal ganglia

Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology

Correction: Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology

Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.

Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primates

GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte-neuron interactions

Human-to-mouse prion-like propagation of mutant huntingtin protein

Inflammation and neurodegeneration: the story ‘retolled’ ⬇️

Is Huntington's disease a tauopathy?

Mutant huntingtin is present in neuronal grafts in Huntington disease patients

MyD88 deficiency results in both cognitive and motor impairments in mice ⬇️

Parkinsonian Motor Deficits Are Reflected by Proportional A9/A10 Dopamine Neuron Degeneration in the Rat ⬇️

Partial neurorescue effects of DHA following a 6-OHDA lesion of the mouse dopaminergic system.

Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases ⬇️

Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease

Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology

Single-cell suspension methodology favors survival and vascularization of fetal striatal grafts in the YAC128 mouse model of Huntington's disease.

Sox6 expression distinguishes dorsally and ventrally biased dopamine neurons in the substantia nigra with distinctive properties and embryonic origins

Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viability.

Striatal neurones displaying substance P (NK 1) receptor immunoreactivity in human and non-human primates ⬇️

Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease.

The different effects of LPS and poly I:C prenatal immune challenges on the behavior, development and inflammatory responses in pregnant mice and their offspring

The fate of cell grafts for the treatment of Huntington's disease: the post-mortem evidence.

The morphological and molecular changes of brain cells exposed to direct current electric field stimulation.

The role of immunity in Huntington's disease ⬇️

The role of tau in the pathological process and clinical expression of Huntington's disease

Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease ⬇️

Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates